aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin]

RxCUI
211292
RxNorm name
aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin]
Display name
ANACIN (Oral Pill)
Full name
aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin]
Term type
SBD
Status
Active
Strength
400-32 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-12 19:37:03

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aspirin400 MG / 1 EACHaspirinaspirin
caffeine32 MG / 1 EACHcaffeinecaffeine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aspirin1191
caffeine1886

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRASA 400 MG / Caffeine 32 MG Oral Tablet [Anacin]1NAMES
RxNorm Nameaspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff1CODES
RxCUI2112921CODES
MMSL_CODEBD49461CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
63736-200-9063736-200Anacin Asprin and CaffeineInsight Pharmaceuticals LLCM013
63736-200-9363736-200Anacin Asprin and CaffeineInsight Pharmaceuticals LLCM013

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01363736-200Anacin Asprin and CaffeineOTC MONOGRAPH DRUGInsight Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 29 matching rows.

NDC11, Source, Active table
NDC11SourceActive
63736020004rxnav_ndcsyes
63736020025rxnav_ndcsyes
63736020030rxnav_ndcsyes
63736020035rxnav_ndcsyes
63736020045rxnav_ndcsyes
63736020050rxnav_ndcsyes
63736020065rxnav_ndcsyes
63736020090rxnav_ndcsyes
63736020091rxnav_ndcsyes
63736020092rxnav_ndcsyes
63736020093rxnav_ndcsyes
63736020095rxnav_ndcsyes
00573020005rxnav_historical
00573020006rxnav_historical
00573020012rxnav_historical
00573020025rxnav_historical
00573020035rxnav_historical
00573020037rxnav_historical
00573020045rxnav_historical
00573020055rxnav_historical
00573020065rxnav_historical
00573020075rxnav_historical
00573020095rxnav_historical
00573020274rxnav_historical
00573020620rxnav_historical
00573020630rxnav_historical
00573020640rxnav_historical
00573026040rxnav_historical
63736020066rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AnacinASPRIN AND CAFFEINEInsight Pharmaceuticals LLC51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff2025-10-23WarningsExact identifier
ndc (package): 63736-200-90
ndc (package): 63736-200-93
ndc (product): 63736-200
ndc11 (package): 63736020030
ndc11 (package): 63736020090
ndc11 (package): 63736020091
ndc11 (package): 63736020093
ndc11 (package): 63736020050
ndc11 (package): 63736020092
ndc11 (package): 63736020004
ndc11 (package): 63736020095
rxcui: 211292

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
51ab0ee3-3c94-424d-a30a-2d6c14e3d8ffANACIN 400 MG / 32 MG Oral Tablet [PSN] · aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin] [SBD] · Anacin (ASA 400 MG / caffeine 32 MG) Oral Tablet [SY] · ASA 400 MG / Caffeine 32 MG Oral Tablet [Anacin] [SY]49Anacin - 63736-20020251023

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
51ab0ee3-3c94-424d-a30a-2d6c14e3d8ffAnacin - 63736-200Insight Pharmaceuticals LLC20251023
51ab0ee3-3c94-424d-a30a-2d6c14e3d8ffAnacin - 63736-200Insight Pharmaceuticals LLC20250116

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA01ADOther agents for local oral treatmentATC1-4aspirin
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCB01ACPlatelet aggregation inhibitors excl. heparinATC1-4aspirin
ATCN02BASalicylic acid and derivativesATC1-4aspirin
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcaspirin
FDASPLN0000175578Platelet Aggregation InhibitorEPChas_epcaspirin
MEDRTD001241AspirinCHEMhas_ingredientaspirin
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treataspirin
MEDRTD001778Blood Coagulation DisordersDISEASEci_withaspirin
MEDRTD001791Blood Platelet DisordersDISEASEci_withaspirin
MEDRTD002544Cerebral InfarctionDISEASEmay_preventaspirin
MEDRTD002644ChickenpoxDISEASEci_withaspirin
MEDRTD002675Child, PreschoolDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_treataspirin
MEDRTD006073GoutDISEASEmay_treataspirin
MEDRTD006396HematemesisDISEASEci_withaspirin
MEDRTD006474Hemorrhagic DisordersDISEASEci_withaspirin
MEDRTD007223InfantDISEASEci_withaspirin
MEDRTD007249InflammationDISEASEmay_treataspirin
MEDRTD002546Ischemic Attack, TransientDISEASEmay_preventaspirin
MEDRTD008551MelenaDISEASEci_withaspirin
MEDRTD009203Myocardial InfarctionDISEASEmay_preventaspirin
MEDRTD009298Nasal PolypsDISEASEci_withaspirin
MEDRTD010003OsteoarthritisDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_preventaspirin
MEDRTD011225Pre-EclampsiaDISEASEmay_preventaspirin
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withaspirin
MEDRTD012213Rheumatic FeverDISEASEmay_treataspirin
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaaspirin
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peaspirin
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peaspirin
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000000026Hepatic MetabolismPKhas_pkaspirin
MEDRTN0000000042Renal ExcretionPKhas_pkaspirin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH400 MG / 32 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable SynonymANACIN 400 MG / 32 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon